Overview

herceptin


Related Overviews

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

A humanized monoclonal antibody that blocks EGF-mediated cell proliferation by binding to the epidermal growth factor receptor (HER2; c-erbB2). Only the subset of breast carcinomas (25–30%) that overexpress HER2 can be treated with this antibody, one of the first examples of the importance of pharmacogenomics. TN Trastuzumab.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.